| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,697 | 33,329 | 37,461 | 37,235 | | Cost of Revenue | 34,589 | 28,292 | 31,693 | 31,627 | | | Gross Profit | 6,108 | 5,037 | 5,768 | 5,608 | | | Operating Expenses | | Research Development | 1,606 | 1,644 | 1,653 | 1,442 | | Selling General and Administrative | 4,489 | 4,261 | 4,299 | 4,252 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 439 | 439 | 439 | 439 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (819) | (1,307) | (623) | (525) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (469) | 64 | (47) | 59 | | Earnings Before Interest And Taxes | (819) | (1,243) | (670) | (466) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (819) | (1,243) | (670) | (466) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (819) | (1,243) | (670) | (466) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (819) | (1,243) | (670) | (466) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($819) | ($1,243) | ($670) | ($466) |
|
0.02% Nasdaq 0.00%
Income Statement
